What is the first-line treatment for a 62-year-old female with stage 1–2 hypertension?

First-Line Treatment for Stage 1-2 Hypertension in a 62-Year-Old Female

For a 62-year-old female with stage 1-2 hypertension, initiate treatment with a thiazide-type diuretic (preferably chlorthalidone), a long-acting calcium channel blocker (CCB), an ACE inhibitor, or an angiotensin receptor blocker (ARB), with thiazide diuretics showing the strongest evidence for cardiovascular event reduction. 1, 2

Treatment Approach Based on Blood Pressure Level

Stage 1 Hypertension (SBP 130-139 or DBP 80-89 mmHg)

• Start with monotherapy using one of the following first-line agents 1, 2:

  • Thiazide/thiazide-like diuretic (Grade A evidence) - preferred option
  • Long-acting CCB (Grade B evidence)
  • ACE inhibitor (Grade B evidence)
  • ARB (Grade B evidence)

• Titrate the dose and add sequential agents if target BP (<140/90 mmHg) is not achieved 3

Stage 2 Hypertension (SBP ≥140 or DBP ≥90 mmHg)

• Initiate combination therapy with 2 first-line agents from different classes, preferably as a single-pill combination 1, 2
• This approach achieves BP control faster and improves medication adherence 1

Recommended Drug Classes and Evidence

Thiazide-Type Diuretics (Strongest Evidence)

Thiazide diuretics, particularly chlorthalidone, demonstrate superior cardiovascular outcomes compared to other first-line agents 4, 5:

• Reduce total cardiovascular events by 12% compared to beta-blockers 5
• Reduce heart failure by 26% compared to CCBs 5
• Reduce stroke by 11% compared to ACE inhibitors 5
• Superior to amlodipine and lisinopril in preventing heart failure 4

Dosing: Chlorthalidone 12.5-25 mg daily or hydrochlorothiazide 25-50 mg daily 6

Important caveat: Monitor for hypokalemia, hyponatremia, and uric acid elevation 6, 3

Calcium Channel Blockers

Long-acting dihydropyridine CCBs (e.g., amlodipine) are equally effective as thiazides for most cardiovascular outcomes except heart failure 5

• Use as first-line alternative if thiazides are not tolerated 4
• Particularly effective in this age group (>60 years) 3

ACE Inhibitors/ARBs

Both classes show similar cardiovascular protection to thiazides and CCBs 5, 7:

• ACE inhibitors may cause more cough and angioedema
• ARBs generally better tolerated
• Do not combine ACE inhibitor + ARB - increases harm without benefit 1, 2

Beta-Blockers: NOT Recommended as First-Line

Beta-blockers are NOT recommended as first-line therapy in patients ≥60 years (Grade A evidence) 3, 8, 3:

• Less effective at preventing stroke (30% higher risk vs. diuretics) 4
• Associated with highest rate of uncontrolled BP (45.9%) 9
• Higher cardiovascular event rates compared to other classes 5, 9

Combination Therapy Strategies

Preferred Two-Drug Combinations

When combination therapy is needed 10, 3:

1. ACE inhibitor or ARB + CCB (Grade A evidence)
2. ACE inhibitor or ARB + thiazide diuretic (Grade B evidence)
3. CCB + thiazide diuretic (Grade B evidence)

Avoid These Combinations

• ACE inhibitor + ARB (increases harm) 1, 2
• Non-dihydropyridine CCB + beta-blocker (caution required) 8

Blood Pressure Targets

Target BP: <140/90 mmHg using office blood pressure measurements 3

• For high-risk patients (cardiovascular disease, diabetes, CKD), consider more intensive target of <130/80 mmHg 4, 1
• In adults ≥65 years, SBP target remains <140 mmHg (some guidelines support <130 mmHg in healthy older adults) 1

Practical Implementation Algorithm

1. Assess cardiovascular risk and comorbidities
2. Stage 1 hypertension: Start thiazide diuretic (chlorthalidone 12.5 mg daily)
3. Stage 2 hypertension: Start combination therapy (e.g., chlorthalidone + amlodipine or chlorthalidone + lisinopril) as single-pill combination
4. Reassess BP in 1 month for stage 2, or 3-6 months for stage 1 6
5. If target not achieved: Increase doses or add third agent from different class
6. Monitor for adverse effects: Electrolytes (2-4 weeks after starting diuretic or ACE inhibitor/ARB), orthostatic hypotension 6

Common Pitfalls to Avoid

• Don't use beta-blockers as first-line in this age group unless compelling indication (e.g., coronary artery disease, heart failure)
• Don't combine ACE inhibitor with ARB - no added benefit, increased harm
• Don't forget to check electrolytes when using thiazides or ACE inhibitors/ARBs
• Don't delay combination therapy in stage 2 hypertension - monotherapy will likely fail
• Don't use alpha-blockers as first-line - less effective than other classes 3, 11